Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Opa-Locka, Florida Clinical Trials

A listing of Opa-Locka, Florida clinical trials actively recruiting patient volunteers.

RESULTS

Found (1216) clinical trials

Efficacy and Safety Study to Treat Subjects With Symptomatic Internal Hemorrhoids Inclusion Criteria for Double-Blind and Recurrence Males or non-pregnant females, aged ≥ 18 to ≤ 75 years. Symptomatic internal hemorrhoids, Grades I-III by direct anoscopic visualization (anoscopic visualization not required if Grade determined by colonoscopy within 28 days prior ...

Phase

3.27 miles

Learn More »

Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain Patient Inclusion Criteria: Male and female subjects ≥ 18 years of age with moderate to severe, chronic low back pain (lasting at least several hours daily) as their ...

Phase

3.27 miles

Learn More »

A Multicentre, International, Randomised, Parallel Group, Double Blind Study to Evaluate Cardiovascular Safety of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk. Eligibility: Ages Eligible for Study: 40 Years to 85 Years Genders Eligible for Study: Both Accepts Healthy Volunteers: No Patient Inclusion Criteria: ...

Phase N/A

3.27 miles

Learn More »

Many people struggle to control their high blood pressure, a disease known as hypertension. New medical treatments can be a way to make high blood pressure easier to control. Medical research works towards finding those new treatments. You will be taking a combination of study medications or a single type ...

Phase

3.27 miles

Learn More »

Adults who have sprained or strained an ankle in the last 48 hours are needed to help evaluate an investigational patch to see if it helps relieve pain. This medical research study is evaluating an investigational patch that is applied to a sprained or strained ankle every 12 hours for ...

Phase N/A

3.27 miles

Learn More »

If you’re taking High Cholesterol medication, you may qualify for a research study. Investigational medication provided at no charge Study-related care from a local doctor at no charge

Phase N/A

3.27 miles

Learn More »

This phase 2 study is a multicenter, exploratory study designed to evaluate the efficiency and safety of Febuxostat 40 mg in subjects with Gout and moderate renal impairment.

Phase

3.27 miles

Learn More »

Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF)

This is an open-label study to evaluate the safety of continued therapy with oral treprostinil in subjects who have completed Study TDE-HF-301. This study will provide long-term, open-label data regarding the effect of continued long-term oral treprostinil therapy for the treatment of pulmonary hypertension (PH) associated with heart failure with ...

Phase

3.39 miles

Learn More »

This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms

The primary objective of the study is to evaluate the effect of empagliflozin 10 mg versus placebo on exercise ability using the 6 minute walk test in patients with chronic HF with reduced ejection fraction (LVEF 40%) Secondary objectives are to assess Patient-Reported Outcome (PRO)

Phase

3.39 miles

Learn More »

A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease

This is an international, multicentre, event-driven, randomized, double-blind, parallel group, placebo-controlled study, evaluating the effect of dapagliflozin versus placebo, given once daily in addition to standard of care, to prevent the progression of chronic kidney disease (CKD) or cardiovascular (CV)/renal death.

Phase

3.43 miles

Learn More »